Your browser doesn't support javascript.
loading
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.
Bosnic-Anticevich, Sinthia; Costa, Elisio; Menditto, Enrica; Lourenço, Olga; Novellino, Ettore; Bialek, Slawomir; Briedis, Vitalis; Buonaiuto, Roland; Chrystyn, Henry; Cvetkovski, Biljana; Di Capua, Stefania; Kritikos, Vicky; Mair, Alpana; Orlando, Valentina; Paulino, Ema; Salimäki, Johanna; Söderlund, Rojin; Tan, Rachel; Williams, Dennis M; Wroczynski, Piotr; Agache, Ioana; Ansotegui, Ignacio J; Anto, Josep M; Bedbrook, Anna; Bachert, Claus; Bewick, Mike; Bindslev-Jensen, Carsten; Brozek, Jan L; Canonica, Giorgio Walter; Cardona, Victoria; Carr, Warner; Casale, Thomas B; Chavannes, Niels H; Correia de Sousa, Jaime; Cruz, Alvaro A; Czarlewski, Wienczyslawa; De Carlo, Giuseppe; Demoly, Pascal; Devillier, Philippe; Dykewicz, Mark S; Gaga, Mina; El-Gamal, Yehia; Fonseca, João; Fokkens, Wytske J; Guzmán, Maria Antonieta; Haahtela, Tari; Hellings, Peter W; Illario, Maddalena; Ivancevich, Juan Carlos; Just, Jocelyne.
Afiliação
  • Bosnic-Anticevich S; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, New South Wales, Australia.
  • Costa E; UCIBIO, REQUIMTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal.
  • Menditto E; CIRFF, Federico II University, Naples, Italy.
  • Lourenço O; Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Novellino E; Department of Pharmacy of University of Naples Federico II, Naples, Italy.
  • Bialek S; Department of Biochemistry and Clinical Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Warsaw Medical University, Warsaw, Poland.
  • Briedis V; Department of Clinical Pharmacy of Lithuanian, University of Health Sciences, Kaunas, Lithuania.
  • Buonaiuto R; Pharmacist, Municipality Pharmacy, Sarno, Italy.
  • Chrystyn H; RiRL, Oakington, Cambridge, UK.
  • Cvetkovski B; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, New South Wales, Australia.
  • Di Capua S; Farmacie Dei Golfi Group, Massa Lubrense, Italy.
  • Kritikos V; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, New South Wales, Australia.
  • Mair A; DG for Health and Social Care, Scottish Government, Edinburgh, UK.
  • Orlando V; CIRFF, Federico II University, Naples, Italy.
  • Paulino E; Farmacias Holon, Lisbon, Portugal.
  • Salimäki J; Association of Finnish Pharmacies, Helsinki, Finland.
  • Söderlund R; Department of Nephrology and Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
  • Tan R; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, New South Wales, Australia.
  • Williams DM; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina.
  • Wroczynski P; Department of Biochemistry and Clinical Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Warsaw Medical University, Warsaw, Poland.
  • Agache I; Transylvania University Brasov, Brasov, Romania.
  • Ansotegui IJ; Department of Allergy and Immunology, Hospital Quirón Bizkaia, Erandio, Spain.
  • Anto JM; ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Bedbrook A; IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
  • Bachert C; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Bewick M; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Bindslev-Jensen C; MACVIA-France, Fondation Partenariale FMC VIA-LR, Montpellier, France.
  • Brozek JL; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
  • Canonica GW; iQ4U Consultants Ltd, London, UK.
  • Cardona V; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
  • Carr W; Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Casale TB; Personalized Medicine Clinic Asthma & Allergy, Humanitas Research Hospital, Humanitas University, Rozzano, Milan, Italy.
  • Chavannes NH; Allergy Section, Department of Internal Medicine, Hospital Vall 'dHebron & ARADyAL Research Network, Barcelona, Spain.
  • Correia de Sousa J; Allergy and Asthma Associates of Southern California, Mission Viejo, California.
  • Cruz AA; Division of Allergy/Immunology, University of South Florida, Tampa, Florida.
  • Czarlewski W; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • De Carlo G; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • Demoly P; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Devillier P; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
  • Dykewicz MS; WHO GARD Planning Group, Brasilia, Brazil.
  • Gaga M; Medical Consulting Czarlewski, Levallois, France.
  • El-Gamal Y; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Fonseca J; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Fokkens WJ; Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, Medical School Saint Antoine, INSERM and UPMC Sorbonne Université, Paris, France.
  • Guzmán MA; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Université Paris Saclay, Saclay, France.
  • Haahtela T; Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri.
  • Hellings PW; ERS President 2017-2018, Athens Chest Hospital, 7th Resp Med Department and Asthma Center, Athens, Greece.
  • Illario M; Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
  • Ivancevich JC; CINTESIS, Center for Research in Health Technologies and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Just J; MEDIDA, Lda, Porto, Portugal.
Allergy ; 74(7): 1219-1236, 2019 07.
Article em En | MEDLINE | ID: mdl-30565275
ABSTRACT
Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmácias / Serviços de Saúde Comunitária / Procedimentos Clínicos / Rinite Alérgica Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmácias / Serviços de Saúde Comunitária / Procedimentos Clínicos / Rinite Alérgica Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article